Wide-reaching changes announced by the Dept. of Health and Human Services would speed up the process of approving and monitoring federally funded clinical trials.
The plans, which represent the first substantive revisions to the country’s human-research subjects regulations since they were adopted three decades ago, could help ease the regulatory burden faced by the estimated 30,000 U.S. physicians who act as clinical investigators.
My latest. Read the whole shebang.